World-first Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight

USANZ Members Damien Bolton and Joseph Ischia's work on high dose intravenous Zinc as a method of reducing Ischaemia-perfusion injury post partial nephrectomy, has been picked up as a potential means of reducing the chronic lung fibrosis that appears to follow COVID-19 infection.

A trial will be commencing this coming week - read more about the trial.

Damien Bolton commented, "It is very interesting to see the parallel inflammatory pathways that exist between the kidney and other organs. It turns out urology can put a finger in any pie!".

Latest Tweets